Biopharma scores victory in ACA health exchange proposed rules
This article was originally published in Scrip
Executive Summary
The biopharmaceutical industry scored a victory on 20 November when the Obama administration revealed a new proposed rule that calls for health plans in the new state insurance exchanges to cover more than one drug from each class of medicines.